Trademarkia Logo

Canada

C$
ALGERNON
REGISTERED

on 13 Dec 2023

Last Applicant/ Owned by

ALGERNON PHARMACEUTICALS INC.

700 West Pender StreetSuite 915Vancouver

BRITISH COLUMBIA

CA

V6C1G8

Serial Number

1946016 filed on 13th Feb 2019

Registration Number

TMA1213765 registered on 13th Dec 2023

Registration expiry Date

13th Dec 2033

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

ALGERNON

Trademark usage description

pharmaceuticals for the use in treatment of cough, lung injury, stroke, multiple sclerosis, parkinson's disease, traumatic brain injury, kidney disord Read More

Classification Information


Class [005]
Pharmaceuticals for the use in treatment of cough, lung injury, stroke, multiple sclerosis, Parkinson's disease, traumatic brain injury, kidney disorders, liver disease, inflammatory bowel disease, ulcerative colitis, diarrhea, fibrosis, neurological injury, cancer, psychiatric disorders, Huntington's disease and Crohns disease.


Classification kind code

11

Mark Details


Serial Number

1946016

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 14th Jun 2023
Registration Pending
Submitted for opposition 42
on 22nd Mar 2023
Advertised
Submitted for opposition 26
on 27th Feb 2023
Approved
Submitted for opposition 27
on 27th Feb 2023
Approval Notice Sent
Submitted for opposition 22
on 11th Aug 2022
Search Recorded
Submitted for opposition 20
on 11th Aug 2022
Examiner's First Report
Submitted for opposition 135
on 14th Feb 2020
Amendment to Application
Submitted for opposition 31
on 15th Feb 2019
Formalized
Submitted for opposition 1
on 14th Feb 2019
Created
Submitted for opposition 30
on 13th Feb 2019
Filed